NDA/BLA filedconf 0.95
dordaviprone — NDA/BLA filed
$JAZZ · Jazz Pharmaceuticals plc · recurrent H3 K27M-mutant diffuse glioma (accelerated approval)
Event date
Date TBD
Sponsor runway
cash-flow +
$1.84B liquid
Evidence
Comparable historical nda/bla fileds· last 5 years · same event type
| Ticker | Drug | Date | Outcome |
|---|---|---|---|
| $AXSM | — | 2025-12-31 | unknown |
| $RCKT | kresladi | 2025-10-14 | unknown |
| $ALDX | reproxalap | 2025-07-17 | unknown |
| $ETON | et-600 | 2025-07-08 | unknown |
| $BCRX | orladeyo (berotralstat) | 2025-05-14 | unknown |
| $CORT | relacorilant | 2025-03-03 | unknown |
| $ALDX | reproxalap | 2024-11-01 | unknown |
| $AXSM | axs-07 | 2024-09-04 | unknown |
| $RCKT | kresladi | 2023-10-02 | unknown |
| $GERN | imetelstat | 2023-08-21 | unknown |
Recent insider activity· ±90 days
2 insiders · 0 buys · 5 sells
Sell10b5-1
2026-05-01COZADD BRUCE C
Director
6,000 @ $203.33$1.22M
Sell10b5-1
2026-04-01COZADD BRUCE C
Director
3,684 @ $190.22$701K
Sell10b5-1
2026-04-01COZADD BRUCE C
Director
2,292 @ $190.94$438K
Sell10b5-1
2026-04-01COZADD BRUCE C
Director
24 @ $191.74$5K
Sell
2026-03-09Carr Patricia
SVP, Chief Accounting Officer
1,287 @ $182.94$235K